Finalist
Haemophilia Academy
Core sponsorship for the Haemophilia Academy is provided as an unrestricted educational grant from Novo Nordisk Health Care AG. Additional sponsorship provided as an unrestricted educational grant from Instrumentation Laboratory
Summary of work
The annual Haemophilia Academy was established based on a European study demonstrating a dramatic decline in the number of trainee physicians interested in a career in bleeding disorders. It was anticipated that developing a unique programme tailored to meet the educational needs of trainee haematologists within a collaborative environment would encourage more physicians to pursue a career in haemophilia, whilst building a network for best-practice sharing and collaboration. Ten years on, the Haemophilia Academy has provided high-quality, specific education for >300 trainee physicians from 64 countries. The five-day course is delivered by an international Faculty of experts in the field, experienced in providing education. CME-accreditation and endorsement from international haemophilia societies ensure the quality of training. Each year over twice as many applications are received as places available.
Results from 2016–2017 show a 100% retention rate in the field of haemophilia*. Many attendees have taken on significantly more responsibility and care for a greater number of haemophilia patients since attending, and 79% have since led or been involved in research projects and publications. Feedback informs us that physicians feel more confident and better equipped to enhance their clinical practice, with access to a network of alumni for support.
Judges’ comments
This long-standing programme from AXON Communications and Novo Nordisk has strong results. It is held in high regard within the industry and is founded on measurable insight.
